V2 Capital’s Merck MRK Stock Holding History

V2 Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$5.34M	Sell	97,442 -17,963	-16%	-$1.02M	2.22%	35
2014 Q4	$6.25M	Sell	115,405 -4,059	-3%	-$226K	2.59%	31
2014 Q3	$6.76M	Sell	119,464 -4,493	-4%	-$252K	2.79%	16
2014 Q2	$6.84M	Buy	123,957 +94	+0.1%	+$5.13K	2.73%	23
2014 Q1	$6.71M	Sell	123,863 -18,371	-13%	-$951K	2.78%	11
2013 Q4	$6.79M	Buy	+142,234	New	+$6.5M	2.83%	15

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

V2 Capital's MRK Position: Q1 2015 in Review

V2 Capital reduced its Merck (MRK) stake by 16% in Q1 2015, selling an estimated $1.02M and leaving 97,442 shares worth $5.34M. The position accounts for 2.22% of the portfolio, ranked #35.

V2 Capital first reported a position in MRK in Q4 2013 and has held it in 6 quarters since. The position peaked at $6.84M in Q2 2014. 1,711 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

V2 Capital held 97,442 shares of Merck worth $5.34M as of Q1 2015.
V2 Capital sold 17,963 Merck shares in Q1 2015, an estimated $1.02M.
Merck made up 2.22% of V2 Capital's portfolio in Q1 2015, its #35 holding.
V2 Capital first reported a position in Merck in Q4 2013 and has held it in 6 quarters since.
V2 Capital's Merck position peaked at $6.84M in Q2 2014.
1,711 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.